Related Experiment Video
Updated: Feb 11, 2026

Plaquing of Herpes Simplex Viruses
Published on: November 5, 2021
Current vaccines for the prevention of herpes zoster
Allister Gibbons1, Anat Galor1,2
1University of Miami Miller School of Medicine/ Bascom Palmer Eye Institute.
Purpose Of Review:
To summarize the recent advances in the prevention of herpes zoster. The recent Food and Drug Administration (FDA) approval of an adjuvanted subunit vaccine may have a significant impact on the prevention of herpes zoster ophthalmicus.
Recent Findings:
There are currently two commercially available vaccines for the prevention of herpes zoster: a live-attenuated vaccine and a new recombinant subunit vaccine. The latter has been shown to be more effective, have fewer contraindications, but requires two separate inoculations, has higher reactogenicity, and has only short-term postmarketing surveillance.
Summary:
The adjuvanted zoster subunit vaccine offers several advantages over the previously available vaccine. Following the current treatment recommendations, physicians should recommend vaccination to all patients older than 50 years of age with no contraindications, this should also prevent ophthalmic complications of the disease.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Electrical Current

